GB0604782D0 - Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders - Google Patents

Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders

Info

Publication number
GB0604782D0
GB0604782D0 GBGB0604782.3A GB0604782A GB0604782D0 GB 0604782 D0 GB0604782 D0 GB 0604782D0 GB 0604782 A GB0604782 A GB 0604782A GB 0604782 D0 GB0604782 D0 GB 0604782D0
Authority
GB
United Kingdom
Prior art keywords
treatment
related disorders
substituted pyrimidinyl
piperazine compounds
food related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0604782.3A
Other versions
GB2435829A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0604782A priority Critical patent/GB2435829A/en
Publication of GB0604782D0 publication Critical patent/GB0604782D0/en
Publication of GB2435829A publication Critical patent/GB2435829A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0604782A 2006-03-09 2006-03-09 Pyrimidinyl-2-piperazine compounds for use in disorders related to food intake Withdrawn GB2435829A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0604782A GB2435829A (en) 2006-03-09 2006-03-09 Pyrimidinyl-2-piperazine compounds for use in disorders related to food intake

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0604782A GB2435829A (en) 2006-03-09 2006-03-09 Pyrimidinyl-2-piperazine compounds for use in disorders related to food intake

Publications (2)

Publication Number Publication Date
GB0604782D0 true GB0604782D0 (en) 2006-04-19
GB2435829A GB2435829A (en) 2007-09-12

Family

ID=36241306

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0604782A Withdrawn GB2435829A (en) 2006-03-09 2006-03-09 Pyrimidinyl-2-piperazine compounds for use in disorders related to food intake

Country Status (1)

Country Link
GB (1) GB2435829A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2822931B1 (en) 2012-03-09 2017-05-03 Inception 2, Inc. Triazolone compounds and uses thereof
MX2015007433A (en) 2012-12-20 2015-12-07 Inception 2 Inc Triazolone compounds and uses thereof.
EA201690230A1 (en) 2013-09-06 2016-07-29 Инсепшн 2, Инк. TRIAZOLONE COMPOUNDS AND THEIR APPLICATIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003299791A1 (en) * 2002-12-20 2004-07-22 Bayer Pharmaceuticals Corporation Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity

Also Published As

Publication number Publication date
GB2435829A (en) 2007-09-12

Similar Documents

Publication Publication Date Title
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
IL192692A0 (en) Compounds for the treatment of inflammatory disorders
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
ZA200808963B (en) Compounds for the treatment of metabolic disorders
ZA200808178B (en) Imidazolothiazole compounds for the treatment of disease
IL185016A0 (en) Compounds for the treatment of proliferative disorders
ZA200803440B (en) Compounds for the treatment of metabolic disorders
EP2139475A4 (en) The use of pde7 inhibitors for the treatment of movement disorders
IL192852A0 (en) Compounds for the treatment of metabolic disorders
ZA200806455B (en) Use of 2-imidazoles for the treatment of CNS disorders
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
GB0604780D0 (en) Use of substituted piperazine compounds for the treatment of food related disorders
IL192877A0 (en) Use of 2-imidazoles for the treatment of cns disorders
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
IL192851A0 (en) Compounds for the treatment of metabolic disorders
GB0604781D0 (en) Use of substituted phenyl-piperazine compounds for the treatment of food related disorders
IL195392A0 (en) Compounds for the treatment of metabolic disorders
PL1982178T3 (en) Methods for the treatment of affective disorders
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
HK1129112A1 (en) 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
GB0604772D0 (en) Use of substituted amine compounds for the treatment of food related disorders
GB0604783D0 (en) Use of substituted oxime compounds for the treatment of food related disorders
IL192982A0 (en) Compounds for the treatment of metabolic disorders
GB0604778D0 (en) Use of substituted amine compouds fo the treatment of food related disorders

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)